ArticleFrontiers in cardiovascular medicine2026
Geriatric nutritional risk index improves risk scoring for mortality after TAVR compared to established scores.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Risk scoring prior TAVR is based on the EuroSCORE II (European System for Cardiac Operative Risk Evaluation) and the STS-score (Society of Thoracic Surgeons) which are complex, and partly prone to investigator bias. The geriatric nutritional risk index (GNRI) can be calculated by five parameters via publicly available formula (age, height, weight, sex, serum albumin), whereas EuroSCORE II and the STS-score require 21 and 69 variables, respectively. The study compares the efficiency of GNRI in predicting 30-day mortality compared to the EuroSCORE II and the STS-score. Furthermore, GNRI risk classes were analysed in the long-term. Methods: 3.470 consecutive patients who underwent TAVR between 2010 and 2023 at our institution were analysed. GNRI calculation produces a linear parameter that can be divided in four risk groups. Results: ROC (receiver operating characteristic) curve analysis demonstrated no difference in predicting 30-day mortality between GNRI vs. EuroSCORE II (AUC = 0.72 vs. 0.69, Conclusions: The GNRI is an objective publicly available score that simplifies risk assessment prior TAVR without any loss of precision compared to the EuroSCORE II and the STS-score.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.